CureDuchenne » PTC Therapeutics http://www.cureduchenne.org Cure Duchenne Muscular Dystrophy: Giving the Children with Duchenne Muscular Dystrophy the Chance for a Lifetime Fri, 05 Nov 2010 18:02:26 +0000 http://wordpress.org/?v=2.8.5 en hourly 1 PTC Therapeutics Announces Additional Study Of Ataluren In Patients With Advanced Nonsense Mutation Duchenne/Becker Muscular Dystrophy http://www.cureduchenne.org/2010/01/ptc-therapeutics-announces-additional-study-of-ataluren-in-patients-with-advanced-nonsense-mutation-duchennebecker-muscular-dystrophy/ http://www.cureduchenne.org/2010/01/ptc-therapeutics-announces-additional-study-of-ataluren-in-patients-with-advanced-nonsense-mutation-duchennebecker-muscular-dystrophy/#comments Tue, 19 Jan 2010 17:23:40 +0000 CureDuchenne http://www.cureduchenne.org/?p=1585
  • Prosensa’s RNA Based Therapeutic PRO051 Shows Favourable Results in the First Systemic Study in Patients with Duchenne Muscular Dystrophy
  • BioMarin Initiates Phase 1 Clinical Study of BMN 195 for Duchenne Muscular Dystrophy
  • Systemic Treatment with AVI-4658 Demonstrates RNA Exon Skipping and Dystrophin Protein Expression in Duchenne Muscular Dystrophy Patients
    • ]]>     Please take some time to read an important announcement regarding PTC Therapeutics and Duchenne muscular dystrophy.

    Read the Article

    *

    Related posts:

    1. Prosensa’s RNA Based Therapeutic PRO051 Shows Favourable Results in the First Systemic Study in Patients with Duchenne Muscular Dystrophy
    2. BioMarin Initiates Phase 1 Clinical Study of BMN 195 for Duchenne Muscular Dystrophy
    3. Systemic Treatment with AVI-4658 Demonstrates RNA Exon Skipping and Dystrophin Protein Expression in Duchenne Muscular Dystrophy Patients

    ]]>     http://www.cureduchenne.org/2010/01/ptc-therapeutics-announces-additional-study-of-ataluren-in-patients-with-advanced-nonsense-mutation-duchennebecker-muscular-dystrophy/feed/ 0